Wednesday, May 8, 2013

Mol Pharm. 2011 Jun 6;8(3):852-66


Mol Pharm. 2011 Jun 6;8(3):852-66. doi: 10.1021/mp100455h. Epub 2011 Apr 15.

Coformulation of doxorubicin and curcumin in poly(D,L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells.

Misra R, Sahoo SK.

Source

Institute of Life Sciences, Nalco Square, Chandrasekharpur, Bhubaneswar, Orissa, India.



http://www.ncbi.nlm.nih.gov/pubmed/21480667







Biomaterials. 2009 Oct;30(29):5737-50. PMID19631377

Mol Pharm. 2011 Jun 6;8(3):852-66. PMID21480667 


No comments:

Post a Comment